Stroke is a major global health concern, causing significant damage to the brain and often leading to long-term complications. In a recent study, researchers investigated the potential of postbiotics, a novel class of microbial products, to improve outcomes for stroke patients. The findings suggest that postbiotic supplementation can help reduce inflammation, oxidative stress, and the risk of pneumonia in these patients, offering a promising alternative to traditional therapies. Stroke and oxidative stress are closely linked, highlighting the importance of this research.

Tackling Inflammation and Oxidative Stress
The study, conducted by a team of researchers in Iran, focused on the effects of postbiotic supplementation in 120 stroke patients admitted to the intensive care unit (ICU). The researchers found that after just 7 days of postbiotic supplementation, the patients showed significant improvements in key biomarkers related to inflammation and oxidative stress.
Specifically, the study revealed that postbiotic supplementation led to:
– Decreased levels of inflammatory markers like IL-1β, MDA, and Hs-CRP
– Increased total antioxidant capacity (TAC) levels, indicating improved ability to fight oxidative stress
These findings suggest that postbiotics can help mitigate the harmful inflammatory and oxidative processes that often occur in the aftermath of a stroke. By targeting these underlying mechanisms, postbiotics may offer a new approach to supporting stroke recovery.
Reducing the Risk of Pneumonia
Another notable outcome of the study was the reduced incidence of pneumonia in the postbiotic group. During the patients’ ICU stay and follow-up period, only 10% of those receiving postbiotic supplementation developed pneumonia, compared to 19% in the control group.
Pneumonia is a common and serious complication for stroke patients, often leading to further complications and slower recovery. The ability of postbiotics to lower the risk of pneumonia is a significant finding, as it highlights their potential to improve clinical outcomes and reduce the burden of post-stroke complications.
Exploring the Gut-Brain Connection
The researchers also examined the impact of postbiotic supplementation on the gut microbiome of the stroke patients. While they did not find statistically significant changes in the gut microbial composition, the study did reveal an increase in the Shannon diversity index, indicating a more diverse and balanced gut microbial community in the postbiotic group.
The gut-brain axis, the bidirectional communication between the gut and the brain, is increasingly recognized as a crucial factor in the recovery and rehabilitation of stroke patients. Click Here